EIF4A1 and cancer: In addition to PatA, eIF4A can be inhibited by a variety of natural compounds currently being investigated for anti-cancer properties, including hippuristanol [16], 15-deoxy-delta 12,14-prostaglandin J2 (15d-PGJ2) [17], silvestrol [18] and synthetic derivatives.